niacin has been researched along with Cancer of Prostate in 3 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wallach, I | 1 |
Jaitly, N | 1 |
Lilien, R | 1 |
D'Amico, AV | 1 |
Toupless, G | 1 |
Lopes, L | 1 |
Valentine, KJ | 1 |
Cormack, RA | 1 |
Tempany, CM | 1 |
Kumar, S | 1 |
Marks, PJ | 1 |
Yokomizo, Y | 1 |
Fujikawa, A | 1 |
Tajiri, T | 1 |
Ota, J | 1 |
Yumura, Y | 1 |
Moriyama, M | 1 |
Mouri, S | 1 |
3 other studies available for niacin and Cancer of Prostate
Article | Year |
---|---|
A structure-based approach for mapping adverse drug reactions to the perturbation of underlying biological pathways.
Topics: Breast Neoplasms; Computational Biology; Databases, Factual; Diabetes Mellitus, Type 2; Drug-Related | 2010 |
Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events.
Topics: Antibiotic Prophylaxis; Drug Interactions; Humans; Male; Middle Aged; Niacin; Preoperative Care; Pro | 2002 |
[Two cases of pellagra associated with chemotherapy of docetaxel, estramustine, dexamethasone].
Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined C | 2010 |